Tandem: Upgrading To Hold On A High-Stakes Pivot Story
2026-06-04 09:37:32 ET
Things weren't looking too hot when I last assessed Tandem Diabetes Care, Inc. ( TNDM ). Despite a small headline Q2 2025 revenue beat, the company missed big on EPS and made a downward revision to its full-year 2025 U.S. sales guidance. I also touched on the competitive landscape within the insulin pump market that featured larger and more established players like Insulet ( PODD ) and Medtronic ( MDT )....
Read the full article on Seeking Alpha
For further details see:
Tandem: Upgrading To Hold On A High-Stakes Pivot StoryNASDAQ: PODD
PODD Trading
1.38% G/L:
$163.30 Last:
895,991 Volume:
$161.48 Open:
PODD Latest News



